1.32 USD
↘ 0.07 (5.06%)AT CLOSE (03:59 PM EST)
TransCode Therapeutics, Inc. Common Stock
RNAZNASDAQ • USD
1.35
↗ 0.03 (2.05%)
POST MARKET (AS OF 07:55 PM EST)
Post Market
AS OF 07:55 PM EST
1.35
↗ 0.03 (2.05%)
Market: CLOSED
Shares of TransCode Therapeutics, Inc. Common Stock (RNAZ) are trading at $1.32. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (167.1%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Nov 13, 2026.
Open?$1.43
High?$1.45
Low?$1.30
Prev. Close?$1.39
Volume?20.9K
Avg. Volume?29.4K
VWAP?$1.37
Rel. Volume?0.71x
Bid / Ask
Bid?$1.20 × 1.0K
Ask?$1.49 × 300
Spread?$0.29
Midpoint?$1.35
Valuation & Ratios
Market Cap?23.5M
Shares Out?16.9M
Float?675.2K
Float %?63.8%
P/E Ratio?N/A
P/B Ratio?-0.85
EPS?-$2.73
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Themes
Employees
12
Market Cap
23.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-09
Address
6 LIBERTY SQUARE
BOSTON, MA 02109
Phone: 857-301-6857
BOSTON, MA 02109
Phone: 857-301-6857
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?23
Short Sent.?51
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.96Distress
Confidence?54%Low
Short InterestElevated
Short % of Float?7.70%Elevated
Short Interest?52.0K
Days to Cover?2.0
Free Float675.2K
Avg Daily Volume26.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.97Adequate
Quick Ratio?1.97Adequate
Cash Ratio?1.55Strong
Debt/Equity?-0.02Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.85CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?167.1%STRONG▾
Peers50
S&P97
ROA?-30.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-22611971
Enterprise Value?$15.8M
Fundamentals ratios updated end of day